220 related articles for article (PubMed ID: 9587957)
1. Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat.
Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
Pharm Res; 1998 Apr; 15(4):599-605. PubMed ID: 9587957
[TBL] [Abstract][Full Text] [Related]
2. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.
Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
Drug Metab Dispos; 1999 Jul; 27(7):827-34. PubMed ID: 10383928
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antinociception of the model opioid peptide [D-penicillamine] enkephalin by P-glycoprotein modulation.
Chen C; Pollack GM
Pharm Res; 1999 Feb; 16(2):296-301. PubMed ID: 10100317
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein.
Sparreboom A; Planting AS; Jewell RC; van der Burg ME; van der Gaast A; de Bruijn P; Loos WJ; Nooter K; Chandler LH; Paul EM; Wissel PS; Verweij J
Anticancer Drugs; 1999 Sep; 10(8):719-28. PubMed ID: 10573204
[TBL] [Abstract][Full Text] [Related]
5. Systemic coadministration of chloramphenicol with intravenous but not intracerebroventricular morphine markedly increases morphine antinociception and delays development of antinociceptive tolerance in rats.
Smith MT; Nielsen CK; Lim-Fraser MY; Wright AW; Lau M
Drug Metab Dispos; 2000 Feb; 28(2):236-44. PubMed ID: 10640523
[TBL] [Abstract][Full Text] [Related]
6. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
[TBL] [Abstract][Full Text] [Related]
7. Effect of prior morphine-3-glucuronide exposure on morphine disposition and antinociception.
Ouellet DM; Pollack GM
Biochem Pharmacol; 1997 May; 53(10):1451-7. PubMed ID: 9260872
[TBL] [Abstract][Full Text] [Related]
8. Effects of a P-glycoprotein inhibitor on brain and plasma concentrations of anti-human immunodeficiency virus drugs administered in combination in rats.
Savolainen J; Edwards JE; Morgan ME; McNamara PJ; Anderson BD
Drug Metab Dispos; 2002 May; 30(5):479-82. PubMed ID: 11950774
[TBL] [Abstract][Full Text] [Related]
9. Effects of quinidine on antinociception and pharmacokinetics of morphine in rats.
Okura T; Morita Y; Ito Y; Kagawa Y; Yamada S
J Pharm Pharmacol; 2009 May; 61(5):593-7. PubMed ID: 19405997
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux.
Groenendaal D; Freijer J; de Mik D; Bouw MR; Danhof M; de Lange EC
Br J Pharmacol; 2007 Jul; 151(5):701-12. PubMed ID: 17471182
[TBL] [Abstract][Full Text] [Related]
11. Influence of biophase distribution and P-glycoprotein interaction on pharmacokinetic-pharmacodynamic modelling of the effects of morphine on the EEG.
Groenendaal D; Freijer J; de Mik D; Bouw MR; Danhof M; de Lange EC
Br J Pharmacol; 2007 Jul; 151(5):713-20. PubMed ID: 17471181
[TBL] [Abstract][Full Text] [Related]
12. Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.
Kruijtzer CM; Beijnen JH; Rosing H; ten Bokkel Huinink WW; Schot M; Jewell RC; Paul EM; Schellens JH
J Clin Oncol; 2002 Jul; 20(13):2943-50. PubMed ID: 12089223
[TBL] [Abstract][Full Text] [Related]
13. Antinociception versus serum concentration relationships following acute administration of intravenous morphine in male and female Sprague-Dawley rats: differences between the tail flick and hot plate nociceptive tests.
South SM; Edwards SR; Smith MT
Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):20-8. PubMed ID: 18671713
[TBL] [Abstract][Full Text] [Related]
14. The influence of hemorrhagic shock on the pharmacokinetics and the analgesic effect of morphine in the rat.
De Paepe P; Belpaire FM; Rosseel MT; Buylaert WA
Fundam Clin Pharmacol; 1998; 12(6):624-30. PubMed ID: 9818295
[TBL] [Abstract][Full Text] [Related]
15. Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat.
Smith GD; Smith MT
Pain; 1995 Jul; 62(1):51-60. PubMed ID: 7478708
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics and tolerance development during multiple intravenous bolus morphine administration in rats.
Ouellet DM; Pollack GM
J Pharmacol Exp Ther; 1997 May; 281(2):713-20. PubMed ID: 9152377
[TBL] [Abstract][Full Text] [Related]
17. N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk.
Wang L; Leggas M; Goswami M; Empey PE; McNamara PJ
Drug Metab Dispos; 2008 Dec; 36(12):2591-6. PubMed ID: 18799806
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites in horses after intravenous administration of four doses.
Hamamoto-Hardman BD; Steffey EP; Weiner D; McKemie DS; Kass P; Knych HK
J Vet Pharmacol Ther; 2019 Jul; 42(4):401-410. PubMed ID: 30919469
[TBL] [Abstract][Full Text] [Related]
20. Concentration-effect relationships of morphine and morphine-6 beta-glucuronide in the rat.
van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Clin Exp Pharmacol Physiol; 1997 May; 24(5):359-64. PubMed ID: 9143788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
